68462-721-01 |
68462-721 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
300 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-01) |
68462-721-05 |
68462-721 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
300 mg/1 |
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-05) |
68462-721-10 |
68462-721 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
300 mg/1 |
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-10) |
68462-721-30 |
68462-721 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
300 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-721-30) |
68462-722-30 |
68462-722 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
450 mg/1 |
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-30) |
68462-722-05 |
68462-722 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
450 mg/1 |
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-05) |
68462-722-01 |
68462-722 |
HUMAN PRESCRIPTION DRUG |
Theophylline |
Theophylline |
TABLET, EXTENDED RELEASE |
ORAL |
20210603 |
N/A |
ANDA |
ANDA212184 |
Glenmark Pharmaceuticals Inc., USA |
THEOPHYLLINE ANHYDROUS |
450 mg/1 |
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68462-722-01) |